市場調查報告書

核酸分離、煉製市場規模,佔有率趨勢分析:各產品、各類型(DNA、RNA)、各用途(藥物研發、腫瘤)、各手法、各最終用途、各地區,市場區隔預測(2018∼2025年)

Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type (DNA, RNA), By Application, By Method (Magnetic Bead, Reagent), By End Use, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 731200
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
核酸分離、煉製市場規模,佔有率趨勢分析:各產品、各類型(DNA、RNA)、各用途(藥物研發、腫瘤)、各手法、各最終用途、各地區,市場區隔預測(2018∼2025年) Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type (DNA, RNA), By Application, By Method (Magnetic Bead, Reagent), By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月13日內容資訊: 英文 175 Pages
簡介

全球核酸分離、煉製市場預測今後將以年複合成長率6.8%擴大,至2025年達到36億美元。遺傳基因定序的成本降低,遺傳學,個人化醫療,診斷的持續性發展,技術進步等促進了市場的成長。

本報告提供全球核酸分離、煉製市場相關調查,市場趨勢與到2025年的預測,各市場區隔趨勢,各地區趨勢,參與企業的簡介等資料彙整。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • SWOT分析
  • 產業分析:波特

第4章 各產品預測與趨勢分析

  • 趨勢分析
  • 套件、試劑
  • 計量儀器

第5章 各類型預測與趨勢分析

  • 趨勢分析
  • DNA分離與純化
  • RNA分離與純化

第6章 各手法商務分析

  • 趨勢分析
  • 管柱為基礎
  • 磁微珠為基礎
  • 試劑為基礎
  • 其他

第7章 市場分類

  • 趨勢分析
  • 腫瘤
  • 精密醫療
  • 診斷
  • 藥物研發、開發
  • 農業、動物研究
  • 其他

第8章 最終用途、趨勢分析

  • 趨勢分析
  • 學術研究機關
  • 製藥公司、生物科技企業
  • CRO
  • 醫院、診斷中心
  • 其他

第9章 各地區預測與趨勢分析

  • 市場佔有率分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭環境

  • 策略架構
  • 市場進入分類
  • 企業簡介
    • QIAGEN
    • ThermoFisher Scientific, Inc.
    • Illumina, Inc.
    • Danaher
    • F Hoffmann-La Roche Ltd.
    • Merck KGaA
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc.
    • General Electric Company (GE healthcare)
    • Takara Bio USA Holdings, Inc.
    • Promega Corporation
    • Norgen Biotek Corp.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-2-68038-580-9

The global nucleic acid isolation and purification market size is expected to reach USD 4.2 billion by 2027, growing at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Nucleic acid isolation is the most basic step deployed in sequencing technologies. Increasing employment of next-generation sequencing (NGS) techniques along with the declining cost of genomic sequencing drives the market.

Ongoing developments of automated nucleic acid extraction systems designed for high-throughput sample processing have significantly simplified the isolation of DNA and RNA, thereby providing lucrative avenues for market growth. These systems potentially reduce the labor costs and time, increase worker safety, laboratory efficiency, reproducibility, and quality of results.

The growing popularity of biopharmaceuticals has led to the development of nucleic acid-based products, such as DNA vaccines, small interfering RNA, and antisense oligonucleotides. These products are applied in therapeutic techniques, such as gene therapy and anti-sense technology, as a powerful tool for medical practitioners to treat cancer, genetic, and infectious diseases. This has boosted the adoption of DNA or RNA isolation techniques in the market.

Further key findings from the report suggest:

  • The instruments segment is expected to grow at a lucrative pace due to the advent of automated extraction systems resulting in high performance and lower cost for DNA extraction
  • DNA isolation methods accounted for the largest revenue share and are anticipated to witness the fastest progress rate due to ongoing discoveries of simple, rapid, and inexpensive methods
  • The high adoption rate of magnetic bead methods is attributive to its largest revenue share
  • This is because the method can isolate nucleic acids directly from the crude sample without much processing
  • This method is also expected to witness the fastest CAGR owing to the development of functionalized magnetic particles that have been incorporated in buffer systems to provide rapid and efficient extraction
  • Oncology application is projected to witness a lucrative growth rate as liquid biopsy techniques and patient-tailored therapies are gaining traction for cancer diagnosis
  • Hospitals and diagnostic centers accounted for the largest share in 2019, in terms of revenue
  • The high incidence rate of genetic and inherited diseases has increased the usage of nucleic acid isolation in early and accurate diagnosis of these conditions in hospitals
  • Better healthcare infrastructure, a substantial number of technology providers, and rapid adoption of NGS has driven the uptake of nucleic acid extraction products in North America at a large scale
  • Asia Pacific is anticipated to exhibit the fastest CAGR over the forecast period owing to significant public and private commitments towards genomics research and precision medicine, thereby prompting the adoption of isolation techniques

QIAGEN, Agilent Technologies, Danaher, Illumina, Roche, and Thermo Fisher are some key companies operating in the nucleic acid isolation and purification market.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation

Chapter 2 Executive Summary

  • 2.1 Nucleic Acid Isolation & Purification Market: Market Outlook
  • 2.2 Nucleic Acid Isolation & Purification Market Segmentation & Scope
  • 2.3 Nucleic Acid Isolation & Purification Market: Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Penetration & Growth Prospect Mapping for Method, 2019
  • 3.2 Nucleic Acid Isolation & Purification Market: Technology Trends
    • 3.2.1 Technology trends
    • 3.2.2 Outsourcing & contract manufacturing trends
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increasing incidence of cancer, genetic disorders, and infectious diseases
      • 3.3.1.2 Increase in public-private funding on biotechnology and life sciences research
      • 3.3.1.3 Advancements in automation
      • 3.3.1.4 Growth in NGS technologies
      • 3.3.1.5 Growing demand for genetically modified crops and organisms
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Expensive instruments and consequent low penetration in emerging countries
      • 3.3.2.2 Challenges related to the use of big data and bioinformatics
  • 3.4 Nucleic Acid Isolation & Purification Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Major Deals & Strategic Alliances Analysis
    • 3.6.1 Agreement
    • 3.6.2 Product developments
    • 3.6.3 Merger & acquisition
    • 3.6.4 Collaboration & partnership

Chapter 4 Nucleic Acid Isolation & Purification Market: Product Estimates & Trend Analysis

  • 4.1 Nucleic Acid Isolation & Purification Market: Product Movement Analysis
  • 4.2 Kits & Reagents
    • 4.2.1 Nucleic acid isolation & purification kits & reagents market, 2016 - 2027 (USD Million)
  • 4.3 Instruments
    • 4.3.1 Nucleic acid isolation & purification instruments market, 2016 - 2027 (USD Million)

Chapter 5 Nucleic Acid Isolation & Purification Market: Type Estimates & Trend Analysis

  • 5.1 Nucleic Acid Isolation & Purification Market: Type Movement Analysis
  • 5.2 DNA Isolation & Purification
    • 5.2.1 DNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.2.2 Genomic DNA isolation & purification
      • 5.2.2.1 Genomic DNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.2.3 Plasmid DNA isolation & purification
      • 5.2.3.1 Plasmid DNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.2.4 Viral DNA isolation & purification
      • 5.2.4.1 Viral DNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.2.5 Other types
      • 5.2.5.1 Other types of DNA isolation & purification market, 2016 - 2027 (USD Million)
  • 5.3 RNA Isolation & Purification
    • 5.3.1 RNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.3.2 miRNA isolation & purification
      • 5.3.2.1 miRNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.3.3 mRNA isolation & purification
      • 5.3.3.1 mRNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.3.4 Total RNA isolation & purification
      • 5.3.4.1 Total RNA isolation & purification market, 2016 - 2027 (USD Million)
    • 5.3.5 Other Types
      • 5.3.5.1 Other types market, 2016 - 2027 (USD Million)

Chapter 6 Nucleic Acid Isolation & Purification Market: Method Estimates & Trend Analysis

  • 6.1 Nucleic Acid Isolation & Purification Market: Method Movement Analysis
  • 6.2 Column Based Isolation & Purification
    • 6.2.1 Column based isolation & purification market, 2016 - 2027 (USD Million)
  • 6.3 Magnetic Bead Based Isolation & Purification
    • 6.3.1 Magnetic bead based isolation & purification market, 2016 - 2027 (USD Million)
  • 6.4 Reagent Based Isolation & Purification
    • 6.4.1 Reagent based isolation & purification market, 2016 - 2027 (USD Million)
  • 6.5 Other Methods
    • 6.5.1 Other methods market, 2016 - 2027 (USD Million)

Chapter 7 Nucleic Acid Isolation & Purification Market: Applications Estimates & Trend Analysis

  • 7.1 Nucleic Acid Isolation & Purification Market: Application Movement Analysis
  • 7.2 Oncology
    • 7.2.1 Oncology medicine market, 2016 - 2027 (USD Million)
  • 7.3 Precision Medicines
    • 7.3.1 Precision medicine market, 2016 - 2027 (USD Million)
  • 7.4 Diagnostics
    • 7.4.1 Diagnostics market, 2016 - 2027 (USD Million)
  • 7.5 Drug Discovery & Development
    • 7.5.1 Drug discovery & development market, 2016 - 2027 (USD Million)
  • 7.6 Agriculture & Animal Research
    • 7.6.1 Agriculture & animal research market, 2016 - 2027 (USD Million)
  • 7.7 Other Applications
    • 7.7.1 Other applications market, 2016 - 2027 (USD Million)

Chapter 8 Nucleic Acid Isolation & Purification Market: End-use Estimates & Trend Analysis

  • 8.1 Nucleic Acid Isolation & Purification Market: End-use Movement Analysis
  • 8.2 Academic Research Institutes
    • 8.2.1 Academic research institutes market, 2016 - 2027 (USD Million)
  • 8.3 Pharmaceutical & Biotechnology Companies
    • 8.3.1 Pharmaceutical and biotechnology companies market, 2016 - 2027 (USD Million)
  • 8.4 Contract Research Organizations
    • 8.4.1 Contract research organisations market, 2016 - 2027 (USD Million)
  • 8.5 Hospitals and Diagnostic Centers
    • 8.5.1 Hospitals and diagnostic centres market, 2016 - 2027 (USD Million)
  • 8.6 Other End-use
    • 8.6.1 Other end-use market, 2016 - 2027 (USD Million)

Chapter 9 Nucleic Acid Isolation & Purification Market: Regional Estimates & Trend Analysis, by Product, Type, Method, Application, & End-use

  • 9.1 Nucleic Acid Isolation & Purification Market Share by Regions, 2019 & 2027
  • 9.2 North America
    • 9.2.1 North America nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.2.2.2 U.S. nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.2.2.3 U.S. nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.2.2.4 U.S. nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.2.2.5 U.S. nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.2.3.2 Canada nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.2.3.3 Canada nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.2.3.4 Canada nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.2.3.5 Canada nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.3.2.2 Germany nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.3.2.3 Germany nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.3.2.4 Germany nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.3.2.5 Germany nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.3.3.2 U.K. nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.3.3.3 U.K. nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.3.3.4 U.K. nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.3.3.5 U.K. nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.4.2.2 Japan nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.4.2.3 Japan nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.4.2.4 Japan nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.4.2.5 Japan nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.4.3.2 China nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.4.3.3 China nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.4.3.4 China nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.4.3.5 China nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.5.2.2 Brazil nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.5.2.3 Brazil nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.5.2.4 Brazil nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.5.2.5 Brazil nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.5.3.2 Mexico nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.5.3.3 Mexico nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.5.3.4 Mexico nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.5.3.5 Mexico nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)
  • 9.6 MEA
    • 9.6.1 MEA nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa nucleic acid isolation & purification market, by product, 2016 - 2027 (USD Million)
      • 9.6.2.2 South Africa nucleic acid isolation & purification market, by type, 2016 - 2027 (USD Million)
      • 9.6.2.3 South Africa nucleic acid isolation & purification market, by method, 2016 - 2027 (USD Million)
      • 9.6.2.4 South Africa nucleic acid isolation & purification market, by application, 2016 - 2027 (USD Million)
      • 9.6.2.5 South Africa nucleic acid isolation & purification market, by end use, 2016 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Company Categorization
  • 10.2 Recent Developments & Impact Analysis, by Key Market Participants
  • 10.3 Public Companies
    • 10.3.1 Company market position analysis
  • 10.4 Private Companies
    • 10.4.1 List of key emerging companies
  • 10.5 Strategy Framework
  • 10.6 Company Profiles
    • 10.6.1 QIAGEN
      • 10.6.1.1 Company overview
      • 10.6.1.2 Financial performance
      • 10.6.1.3 Product benchmarking
      • 10.6.1.4 Strategic initiatives
    • 10.6.2 Thermo Fisher Scientific, Inc.
      • 10.6.2.1 Company overview
      • 10.6.2.2 Life Technologies Corporation
      • 10.6.2.2.1 Company overview
      • 10.6.2.3 Financial performance
      • 10.6.2.4 Product benchmarking
      • 10.6.2.5 Strategic initiatives
    • 10.6.3 Illumina, Inc.
      • 10.6.3.1 Company overview
      • 10.6.3.2 Epicentre
      • 10.6.3.2.1 Company overview
      • 10.6.3.3 Financial performance
      • 10.6.3.4 Product benchmarking
      • 10.6.3.5 Strategic initiatives
    • 10.6.4 Danaher
      • 10.6.4.1 Company overview
      • 10.6.4.2 Beckman Coulter, Inc.
      • 10.6.4.2.1 Company overview
      • 10.6.4.3 Financial performance
      • 10.6.4.4 Product benchmarking
      • 10.6.4.5 Strategic initiatives
    • 10.6.5 F. Hoffmann-La Roche Ltd.
      • 10.6.5.1 Company overview
      • 10.6.5.2 Financial performance
      • 10.6.5.3 Product benchmarking
      • 10.6.5.4 Strategic initiatives
    • 10.6.6 Merck KGaA
      • 10.6.6.1 Company overview
      • 10.6.6.2 Sigma-Aldrich Co. LLC
      • 10.6.6.2.1 Company overview
      • 10.6.6.3 Financial performance
      • 10.6.6.4 Product benchmarking
      • 10.6.6.5 Strategic initiatives
    • 10.6.7 Agilent Technologies, Inc.
      • 10.6.7.1 Company overview
      • 10.6.7.2 Financial performance
      • 10.6.7.3 Product benchmarking
      • 10.6.7.4 Strategic initiatives
    • 10.6.8 Bio-Rad Laboratories, Inc.
      • 10.6.8.1 Company overview
      • 10.6.8.2 Financial performance
      • 10.6.8.3 Product benchmarking
      • 10.6.8.4 Strategic initiatives
    • 10.6.9 GE Healthcare
      • 10.6.9.1 Company overview
      • 10.6.9.2 Financial performance
      • 10.6.9.3 Product benchmarking
      • 10.6.9.4 Strategic initiatives
    • 10.6.10 Takara Bio USA Holdings, Inc.
      • 10.6.10.1 Company overview
      • 10.6.10.2 Clontech Laboratories, Inc.
      • 10.6.10.2.1 Company overview
      • 10.6.10.3 Financial performance
      • 10.6.10.4 Product benchmarking
      • 10.6.10.5 Strategic initiatives
    • 10.6.11 Promega Corporation
      • 10.6.11.1 Company overview
      • 10.6.11.2 Financial performance
      • 10.6.11.3 Product benchmarking
      • 10.6.11.4 Strategic initiatives
    • 10.6.12 Norgen Biotek Corp.
      • 10.6.12.1 Company overview
      • 10.6.12.2 Financial performance
      • 10.6.12.3 Product benchmarking
      • 10.6.12.4 Strategic initiatives
    • 10.6.13 New England Biolabs
      • 10.6.13.1 Company overview
      • 10.6.13.2 Financial performance
      • 10.6.13.3 Product benchmarking
      • 10.6.13.4 Strategic initiatives
    • 10.6.14 AUTOGEN INC.
      • 10.6.14.1 Company overview
      • 10.6.14.2 Financial performance
      • 10.6.14.3 Product benchmarking
      • 10.6.14.4 Strategic initiatives
    • 10.6.15 LGC Biosearch Technologies
      • 10.6.15.1 Company overview
      • 10.6.15.2 Financial performance
      • 10.6.15.3 Product benchmarking
      • 10.6.15.4 Strategic initiatives
    • 10.6.16 Biogenuix
      • 10.6.16.1 Company overview
      • 10.6.16.2 Financial performance
      • 10.6.16.3 Product benchmarking
      • 10.6.16.4 Strategic initiatives
    • 10.6.17 PCR Biosystems Inc.
      • 10.6.17.1 Company overview
      • 10.6.17.2 Financial performance
      • 10.6.17.3 Product benchmarking
      • 10.6.17.4 Strategic initiatives
    • 10.6.18 MagGenome
      • 10.6.18.1 Company overview
      • 10.6.18.2 Financial performance
      • 10.6.18.3 Product benchmarking
      • 10.6.18.4 Strategic initiatives
    • 10.6.19 Axon Scientific Sdn. Bhd.
      • 10.6.19.1 Company overview
      • 10.6.19.2 Financial performance
      • 10.6.19.3 Product benchmarking
      • 10.6.19.4 Strategic initiatives
    • 10.6.20 Abcam plc
      • 10.6.20.1 Company overview
      • 10.6.20.2 Financial performance
      • 10.6.20.3 Product benchmarking
      • 10.6.20.4 Strategic initiatives

List of Tables

  • TABLE 1 Use of nucleic acid isolation and purification techniques across various aspects of disease management
  • TABLE 2 Sequencing-related preparation procedures and their use
  • TABLE 3 North America nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 4 North America nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 5 North America DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 6 North America RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 7 North America nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 8 North America nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 9 North America nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 10 U.S. nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 11 U.S. nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 12 U.S. DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 13 U.S. RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 14 U.S. nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 15 U.S. nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 16 U.S. nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 17 Canada nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 18 Canada nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 19 Canada DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 20 Canada RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 21 Canada nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 22 Canada nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 23 Canada nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 24 Europe nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 25 Europe nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 26 Europe DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 27 Europe RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 28 Europe nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 29 Europe nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 30 Europe nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 31 Germany nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 32 Germany nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 33 Germany DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 34 Germany RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 35 Germany nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 36 Germany nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 37 Germany nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 38 U.K. nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 39 U.K. nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 40 U.K. DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 41 U.K. RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 42 U.K. nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 43 U.K. nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 44 U.K. nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 45 Asia Pacific nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 46 Asia Pacific nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 47 Asia Pacific DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 48 Asia Pacific RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 49 Asia Pacific nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 50 Asia Pacific nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 51 Asia Pacific nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 52 Japan nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 53 Japan nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 54 Japan DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 55 Japan RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 56 Japan nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 57 Japan nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 58 Japan nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 59 China nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 60 China nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 61 China DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 62 China RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 63 China nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 64 China nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 65 China nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 66 Latin America nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 67 Latin America nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 68 Latin America DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 69 Latin America RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 70 Latin America nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 71 Latin America nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 72 Latin America nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 73 Brazil nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 74 Brazil nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 75 Brazil DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 76 Brazil RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 77 Brazil nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 78 Brazil nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 79 Brazil nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 80 Mexico nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 81 Mexico nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 82 Mexico DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 83 Mexico RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 84 Mexico nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 85 Mexico nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 86 Mexico nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 87 MEA nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 88 MEA nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 89 MEA DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 90 MEA RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 91 MEA nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 92 MEA nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 93 MEA nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 94 South Africa nucliec acid isolation & purification market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 95 South Africa nucliec acid isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 96 South Africa DNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 97 South Africa RNA isolation & purification market estimates & forecasts, by type, 2016 - 2027 (USD Million)
  • TABLE 98 South Africa nucliec acid isolation & purification market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 99 South Africa nucliec acid isolation & purification market estimates & forecasts, by method, 2016 - 2027 (USD Million)
  • TABLE 100 South Africa nucliec acid isolation & purification market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 101 List of key emerging companies

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market summary
  • FIG. 9 Penetration & growth prospect mapping for method, 2019
  • FIG. 10 Market trends & outlook
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Global cancer incidence, as of September 2018
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 SWOT analysis, by factor (Political & legal, economic and technological)
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Nucleic acid isolation & purification market: Product outlook key takeaways
  • FIG. 17 Nucleic acid isolation & purification market: Product movement analysis
  • FIG. 18 Nucleic acid isolation & purification kits & reagents market, 2016 - 2027 (USD Million)
  • FIG. 19 Nucleic acid isolation & purification instruments market, 2016 - 2027 (USD Million)
  • FIG. 20 Nucleic acid isolation & purification market type outlook key takeaways
  • FIG. 21 Nucleic acid isolation & purification market: Type movement analysis
  • FIG. 22 DNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 23 Genomic DNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 24 Plasmid DNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 25 Viral DNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 26 Other types of DNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 27 RNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 28 miRNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 29 mRNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 30 Total RNA isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 31 Other types market, 2016 - 2027 (USD Million)
  • FIG. 32 Nucleic acid isolation & purification market: Method outlook key takeaways
  • FIG. 33 Nucleic acid isolation & purification market: Method movement analysis
  • FIG. 34 Column based isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 35 Magnetic bead based isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 36 Reagent based isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 37 Other methods market, 2016 - 2027 (USD Million)
  • FIG. 38 Nucleic acid isolation & purification market Application outlook key takeaways
  • FIG. 39 Nucleic acid isolation & purification market: Application movement analysis
  • FIG. 40 Oncology medicine market, 2016 - 2027 (USD Million)
  • FIG. 41 Precision medicine market, 2016 - 2027 (USD Million)
  • FIG. 42 Diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 43 Drug discovery & development market, 2016 - 2027 (USD Million)
  • FIG. 44 Agriculture & animal research market, 2016 - 2027 (USD Million)
  • FIG. 45 Other applications market, 2016 - 2027 (USD Million)
  • FIG. 46 Nucleic acid isolation & purification market End-use outlook key takeaways
  • FIG. 47 Nucleic acid isolation & purification market: End use movement analysis
  • FIG. 48 Academic research institutes market, 2016 - 2027 (USD Million)
  • FIG. 49 Pharmaceutical and biotechnology companies market, 2016 - 2027 (USD Million)
  • FIG. 50 Contract research organisations market, 2016 - 2027 (USD Million)
  • FIG. 51 Hospitals and diagnostic centres market, 2016 - 2027 (USD Million)
  • FIG. 52 Other end-use market, 2016 - 2027 (USD Million)
  • FIG. 53 Regional market place: Key takeaway
  • FIG. 54 Nucleic acid isolation & purification market regional outlook, 2019 & 2027
  • FIG. 55 North America nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 56 U.S. nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 57 Canada nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 58 Europe nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 59 Germany nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 60 U.K. nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 61 Asia Pacific nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 62 Japan nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 63 China nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 64 Latin America nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 65 Brazil nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 66 Mexico nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 67 MEA nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 68 South Africa nucleic acid isolation & purification market, 2016 - 2027 (USD Million)
  • FIG. 69 Nucleic acid isolation & purification market: Company categorization
  • FIG. 70 Impact analysis by key companies
  • FIG. 71 Market position analysis for public companies
  • FIG. 72 Strategy framework